Lose Weight with Semaglutide Injections (Ozempic, Wegovy) in Our Houston Clinic

Have you given up on finally reaching your dream body? Well, its not your fault. Losing weight can be extremely confusing and challenging, especially with so many diets out there.

Our Houston weight loss clinic offers you a new solution that's been making waves Nationwide: Semaglutide injections (commercially Wegovy® or Ozempic®) 

What are Semaglutide Injections ( Ozempic, Wegovy)?

Semaglutide is the first FDA-approved drug for weight loss in adults with obesity or overweight. Administered once weekly via a subcutaneous injection, Semaglutide is highly effective for chronic weight management.

Proven Benefits of Semaglutide Injections (Ozempic, Wegovy)

Clinical studies have consistently demonstrated the significant benefits of Semaglutide for weight loss and overall health. They include:

• Effective Weight Loss: A mean weight loss of 14.9% (the equivalent of 37 lbs loss for a starting weight of 250 lb) when combined with personalized weight loss programs^1,2.
• Suppressed Appetite: Semaglutide helps reduce energy intake  by suppressing appetite, thanks to its effects on the brain^1,3.
• Improved Cardiometabolic Health: Participants experienced reductions in waist circumference, blood pressure, HbA1c, and lipid levels. There were also greater decreases in C-reactive protein, a marker of inflammation^1,4,5.
• Enhanced Quality of Life: Better physical functioning and improvements in health-related quality of life¹.
• Clinically Meaningful Results: An impressive 86% of participants lost 5% or more of their baseline body weight, compared to only 32% in the placebo group¹.

How Semaglutide Works

Semaglutide mimicks the GLP-1 hormone, which manages blood sugar levels , supporting long-term weight management ⁶. Semaglutide:

• Increases insulin secretion and suppresses glucagon: Helps stabilize blood suga

• Slows gastric emptying and helps regulate appetite: Making you feel fuller for longer

• Activates various metabolic pathways: Improves glucose metabolism, and reduces inflammation

Semaglutide Injections Side Effects

While Semaglutide is effective, it is important to be aware of potential side effects, which are generally mild to moderate and temporary, including :

• Nausea
• Vomiting
• Diarrhea

Who is Ineligible to Take Semaglutide? 

Semaglutide injections ( Wegovy® , Ozempic®) are not for everyone. They are not recommended for individuals with:

• A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Are allergic to Semaglutide or any of its excipient
• Are pregnant
• Have severe gastrointestinal disease
• Suffer from diabetic retinopathy

Please share your entire medical history with our MD, and they will decide if you are eligible for these injections. 

Here’s Why Live Lean is the Best Choice For Your Semaglutide Injections:

Personalized weight loss programs:  We will provide you with exact quantities to consume, recommendations for healthy products, as well as easy recipes to help you reach your weight loss goals faster. We have successfully helped over 3,700 clients to date! 

Regular follow-ups and bi-weekly diet adjustments: to prevent plateaus and maximize your weight loss journey.

Body composition tracking: Ensure you're losing fat, not muscle, by tracking your body composition beyond just the scale.

Learn Healthy Habits: Learn to make healthier choices with our support. From picking the healthiest bread at the grocery store to mastering ordering at restaurants.

Support in weaning off Semaglutide injections: We help you maintain weight loss and develop healthy habits to prevent regaining weight after stopping the injections.

Enjoy the highest standard of care in our modern weight loss Houston clinic equipped with the latest  technology.

Finally Achieve the Weight Loss You Have Been Dreaming Of!

Contact us today to schedule a consultation and learn more about how we can help you achieve your weight loss goals. 

References:

1. Wilding John P.H., Batterham Rachel L., Calanna Salvatore, Davies Melanie, Van Gaal Luc F., Lingvay Ildiko, McGowan Barbara M., Rosenstock Julio, Tran Marie T.D., Wadden Thomas A., Wharton Sean, Yokote Koutaro, Zeuthen Niels, & Kushner Robert F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

2. Kushner, R. F., Calanna, S., Davies, M., Dicker, D., Garvey, W. T., Goldman, B., Lingvay, I., Thomsen, M., Wadden, T. A., Wharton, S., Wilding, J. P. H., & Rubino, D. (2020). Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity, 28(6), 1050–1061. https://doi.org/10.1002/oby.22794

3. Friedrichsen, M., Breitschaft, A., Tadayon, S., Wizert, A., & Skovgaard, D. (2021). The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes, Obesity and Metabolism, 23(3), 754–762. https://doi.org/10.1111/dom.14280

4. Phillips, A., & Clements, J. N. (2022). Clinical review of subcutaneous semaglutide for obesity. Journal of Clinical Pharmacy and Therapeutics, 47(2), 184–193. https://doi.org/10.1111/jcpt.13574

5. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). Identifier NCT03574597. (n.d.). Semaglutide effects on heart disease and stroke in patients with overweight or obesity (SELECT). Retrieved 22 July 2024, from http://clinicaltrials.gov/ct2/show/NCT03574597

6. Smits, M. M., & Van Raalte, D. H. (2021). Safety of Semaglutide. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.645563